Genetic Status of Estrogen Receptor Modifies the Relation of Postmenopausal Hormone Therapy with Carotid Atherosclerosis Among Older Postmenopausal Women. The Three-city Cohort Study

被引：0
|
作者：
Canonico, Marianne [1 ]
Giroud, Maurice [2 ,3 ]
Ryan, Joanne [4 ]
Helmer, Catherine [5 ]
Scarabin, Pierre-Yves [1 ]
机构：
[1] INSERM, U1018, Villejuif, France
[2] Univ Dijon, Fac Med, F-21004 Dijon, France
[3] Univ Dijon, EA 4184, Univ Burgundy, F-21004 Dijon, France
[4] INSERM, U1061, Montpellier, France
[5] INSERM, U897, Bordeaux, France
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Epidemiology; Estrogen; Genetics; Arteriosclerosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
12978
引用
收藏
页数：1
相关论文
共 9 条
  • [1] Plasma Estradiol Levels, Estrogen Receptor Polymorphisms and Ischemic Arterial Disease in Postmenopausal Women: The Three-city Prospective Cohort Study
    Scarabin-Carre, Valerie
    Brailly-Tabard, Sylvie
    Giroud, Maurice
    Ryan, Joanne
    Helmer, Catherine
    Guiochon-Mantel, Anne
    Canonico, Marianne
    Scarabin, Pierre-Yves
    CIRCULATION, 2013, 128 (22)
  • [2] High Plasma Estradiol Level as an Independent Risk Factor for Ischemic Arterial Disease Among Postmenopausal Women. A Population-Based Study (the Three-City Cohort Study)
    Canonico, Marianne
    Scarabin, Valerie
    Brailly-Tabard, Sylvie
    Setiao, Julie
    Trabado, Severine
    Tzourio, Christophe
    Ritchie, Karen
    Dartigues, Jean-Francois
    Guiochon-Mantel, Anne
    Scarabin, Pierre-Yves
    CIRCULATION, 2011, 124 (21)
  • [3] Endogenous oestradiol as a positive correlate of plasma fibrinogen among older postmenopausal women: a population-based study (the Three-City cohort study)
    Canonico, Marianne
    Brailly-Tabard, Sylvie
    Gaussem, Pascale
    Setiao, Julie
    Rouaud, Olivier
    Ryan, Joanne
    Carcaillon, Laure
    Guiochon-Mantel, Anne
    Scarabin, Pierre-Yves
    CLINICAL ENDOCRINOLOGY, 2012, 77 (06) : 905 - 910
  • [4] Postmenopausal Hormone Therapy and Colorectal Cancer Risk in Relation to Somatic KRAS Mutation Status among Older Women
    Limburg, Paul J.
    Limsui, David
    Vierkant, Robert A.
    Tillmans, Lori S.
    Wang, Alice H.
    Lynch, Charles F.
    Anderson, Kristin E.
    French, Amy J.
    Haile, Robert W.
    Harnack, Lisa J.
    Potter, John D.
    Slager, Susan L.
    Smyrk, Thomas C.
    Thibodeau, Stephen N.
    Cerhan, James R.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (04) : 681 - 684
  • [5] Relation of serum levels of estrogen and dehydroepiandrosterone sulfate to hormone receptor status among postmenopausal women with breast cancer.
    Kakugawa Y.
    Minami Y.
    Tateno H.
    Inoue H.
    Fujiya T.
    Breast Cancer, 2007, 14 (3) : 269 - 276
  • [6] Breast Cancer Incidence and Mortality in Relation to Hormone Replacement Therapy Use Among Postmenopausal Women: Results From a Prospective Cohort Study
    Jiang, Yi
    Xie, Qinli
    Chen, Rong
    CLINICAL BREAST CANCER, 2022, 22 (02) : E206 - E213
  • [7] Hormone therapy and venous thromboembolism among postmenopausal women -: Impact of the route of estrogen administration and progestogens:: The ESTHER study
    Canonico, Marianne
    Oger, Emmanuel
    Plu-Bureau, Genevieve
    Conard, Jacqueline
    Meyer, Guy
    Levesque, Herve
    Trillot, Nathalie
    Barrellier, Marie-Therese
    Wahl, Denis
    Emmerich, Joseph
    Scarabin, Pierre-Yves
    CIRCULATION, 2007, 115 (07) : 840 - 845
  • [8] Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The Vascular Aging (EVA) Study
    Le Gal, G
    Gourlet, V
    Hogrel, P
    Plu-Bureau, G
    Touboul, PJ
    Scarabin, PY
    ATHEROSCLEROSIS, 2003, 166 (01) : 163 - 170
  • [9] Associations Between Serum Reproductive Hormone Concentrations and Hormonal Receptor Status Among Postmenopausal Chinese Women With Breast Cancer: An Observational Study
    Jiang, Chuner
    Wu, Peng
    He, Xiangming
    Ni, Jianfen
    Ding, Xiaowen
    Xu, Xiaohong
    Wang, Fangzheng
    Zou, Dehong
    FRONTIERS IN ONCOLOGY, 2022, 12
1